Navigation Links
Extraordinary General Meetings Statement - XTL Notifies NASDAQ of Compliance with Marketplace Rule 4350(d)(2)
Date:10/10/2008

VALLEY COTTAGE, N.Y., Oct. 10 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB; TASE: XTL) announces the results of its Extraordinary General Meetings ("EGMs") held earlier today.

The outcome of the EGMs was as follows: all of the resolutions passed and Jennifer L. Good and Kenneth J. Zuerblis were appointed as External Directors of the Company until October 10, 2011. Following the EGMs, XTL's Audit Committee consists of Mr. Zuerblis, Ms. Good and Dr. William Kennedy.

With the election of the External Directors by the shareholders and their automatic inclusion in the Audit Committee, XTL has notified NASDAQ that it currently has a valid Audit Committee under the Israeli Companies Act and NASDAQ Marketplace Rule 4350(d)(2).

ABOUT XTL BIOPHARMACEUTICALS LTD.

XTL Biopharmaceuticals Ltd. ("XTL") is engaged in the development of therapeutics for the treatment of diabetic neuropathic pain and HCV. XTL is developing Bicifadine, a triple reuptake inhibitor of serotonin, norepinephrine and dopamine, which is currently in a Phase 2b study for the treatment of diabetic neuropathic pain. XTL has out-licensed its novel pre-clinical HCV small molecule inhibitor program. XTL is publicly traded on the NASDAQ and Tel-Aviv Stock Exchanges (Nasdaq: XTLB; TASE: XTL).


'/>"/>
SOURCE XTL Biopharmaceuticals Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") Notices Posted to Shareholders
2. Ten Extraordinary Innovations Line Up For US $100,000 Saatchi & Saatchi Award For World Changing Ideas
3. Call for Entries - 2008 CURE Extraordinary Healer Award for Oncology Nursing
4. Results of Court Meeting and Extraordinary General Meeting - Shareholders Approve Scheme of Arrangement and New Share Plans
5. CURE Magazine Announces Winner of 2008 Extraordinary Healer Award
6. Notification of Record Date for the Annual General Meeting and Extraordinary General Meeting
7. Sinovac Announces Postponement of Annual General Meeting
8. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
9. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
10. CryoLife Names Philip Theodore as Vice President, General Counsel
11. 3SBio Inc. to Hold Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Rocky Mount, NC (PRWEB) September 02, 2014 ... the establishment of its 11th clinical research site: PMG ... has assumed ownership and operation of the clinical research ... NC, further expanding PMG’s presence in eastern North Carolina. ... 130,000 patients. For the patients in Rocky Mount and ...
(Date:9/1/2014)... The global oligonucleotide synthesis market ... from $1,070.7 million in 2014, growing at a ... global oligonucleotide synthesis market is categorized on the ... and geography. The synthesized oligonucleotides segment is expected ... oligonucleotide synthesis market during the forecast period, owing ...
(Date:8/31/2014)... August 31, 2014 This is ... state of the Epoxy Hardener industry in ... overview of the industry, including definitions, applications and ... domestic market analysis are provided with a focus ... the market. A comparison between the international and ...
(Date:8/29/2014)... August 29, 2014 According to a new ... the global orthobiologics market was valued at USD 3,754.6 million ... USD 5,519.9million in 2019at a CAGR of 5.9% from 2013 ... years and above is afflicted by bone and joint disorders, ... year 2020. This has and will continue to increase the ...
Breaking Biology Technology:PMG Research Announces the Formation of its Eleventh Site 2PMG Research Announces the Formation of its Eleventh Site 39.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 29.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 39.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 49.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 5Epoxy Hardener Industry Development Trends in Global & China Regions Now Available at ReportsnReports.com 2Epoxy Hardener Industry Development Trends in Global & China Regions Now Available at ReportsnReports.com 3Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 2Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 3
... 29 Abt Associates has been,ranked 19th in the ... 50 U.S. Research firms. The listing is based on ... research revenue for,calendar 2007 was $55.1 million. Total company ... $225 million., Abt Associates market research activities are ...
... Purification Testing, Standards and Procedures, SHAANXI, China, ... (OTC Bulletin Board: HFGB), a leading,developer and producer ... the,production of pharmaceuticals, nutraceuticals and food production, today,released ... application for COS,approval for the delivery of Diosmin ...
... Volcano Corporation,(Nasdaq: VOLC ), a leading ... (FM) and Optical Coherence,Tomography (OCT) products designed to ... vascular disease, today announced that it will,report its ... six months of,fiscal 2008 on Tuesday, August 5., ...
Cached Biology Technology:Abt Associates Ranked One of Top 20 U.S. Market Research Firms 2Huifeng Bio-Pharmaceutical (HFGB) Provides Update on COS Application Status 2Huifeng Bio-Pharmaceutical (HFGB) Provides Update on COS Application Status 3Volcano Corporation Schedules Second Quarter Conference Call, Webcast 2
(Date:9/2/2014)... the battle between our immune systems and cholera bacteria, ... known as phages. In a new study, researchers from ... National Public Health Laboratory, and elsewhere, report that phages ... in order to survive. Importantly, the study published ... escape from phage predation occurs during human infection. , ...
(Date:9/2/2014)... Kean stops by Reactions this week to debunk the ... despite what "Shark Week" may lead you to believe, ... http://youtu.be/KhFygIoW_MA . , Kean,s book, "The Disappearing Spoon: And ... of the World from the Periodic Table of the ... video series produced for the newly launched American Association ...
(Date:9/2/2014)... touch a hot oven, you rapidly pull your hand ... in sensing and responding to such painful stimuli, they ... researchers have made a surprising discovery about the role ... and have built a structural model of the molecule. ... , may help direct new strategies to treat pain ...
Breaking Biology News(10 mins):War between bacteria and phages benefits humans 2War between bacteria and phages benefits humans 3Surprising new role for calcium in sensing pain 2Surprising new role for calcium in sensing pain 3
... University of the Negev researcher Dr. Taleb Mokari, a ... and Technology, has been awarded a prestigious Krill Prize ... the Prize for his work on developing novel nanostructures ... a senior lecturer in BGU,s Department of Chemistry. His ...
... of time families spend eating meals together has been ... teens, with families who eat together regularly reporting declines ... their children. Now, a new study that looks at ... family interactions during mealtime affected the children,s health. ...
... percent of dairy herds and causes an estimated annual ... A contagious, chronic and usually fatal bacterial infection of ... milk production, causes weight loss in cows, and contributes ... Institute for Mathematical and Biological Synthesis (NIMBioS) is now ...
Cached Biology News:Family mealtimes play a role in health of children with asthma 2Wasting disease in cattle focus of workshop 2